Scolaris Content Display Scolaris Content Display

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 1 Cognitive function (change from baseline at 24 weeks) ITT‐LOCF.
Figuras y tablas -
Analysis 1.1

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 1 Cognitive function (change from baseline at 24 weeks) ITT‐LOCF.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 2 Total number of withdrawals at 24 weeks.
Figuras y tablas -
Analysis 1.2

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 2 Total number of withdrawals at 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 3 Total number of withdrawals due to adverse event at 24 weeks.
Figuras y tablas -
Analysis 1.3

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 3 Total number of withdrawals due to adverse event at 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 4 Total number of patients who suffered at least one adverse event by 24 weeks.
Figuras y tablas -
Analysis 1.4

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 4 Total number of patients who suffered at least one adverse event by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 5 Total number of patients who suffered at least one adverse event of diarrhoea by 24 weeks.
Figuras y tablas -
Analysis 1.5

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 5 Total number of patients who suffered at least one adverse event of diarrhoea by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 6 Total number of patients who suffered at least one adverse event of nausea by 24 weeks.
Figuras y tablas -
Analysis 1.6

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 6 Total number of patients who suffered at least one adverse event of nausea by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 7 Total number of patients who suffered at least one adverse event of vomiting by 24 weeks.
Figuras y tablas -
Analysis 1.7

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 7 Total number of patients who suffered at least one adverse event of vomiting by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 8 Total number of patients who suffered at least one adverse event of leg cramps by 24 weeks.
Figuras y tablas -
Analysis 1.8

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 8 Total number of patients who suffered at least one adverse event of leg cramps by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 9 Total number of patients who suffered at least one adverse event of abnormal dreams by 24 weeks.
Figuras y tablas -
Analysis 1.9

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 9 Total number of patients who suffered at least one adverse event of abnormal dreams by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 10 Total number of patients who suffered at least one adverse event of depression by 24 weeks.
Figuras y tablas -
Analysis 1.10

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 10 Total number of patients who suffered at least one adverse event of depression by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 11 Total number of patients who suffered at least one adverse event of insomnia by 24 weeks.
Figuras y tablas -
Analysis 1.11

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 11 Total number of patients who suffered at least one adverse event of insomnia by 24 weeks.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 12 Number who progress to AD or another dementia after 1 year of treatment.
Figuras y tablas -
Analysis 1.12

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 12 Number who progress to AD or another dementia after 1 year of treatment.

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 13 Number who progress to AD or another dementia after 3 years of treatment.
Figuras y tablas -
Analysis 1.13

Comparison 1 donepezil (10mg/day) vs placebo, Outcome 13 Number who progress to AD or another dementia after 3 years of treatment.

Comparison 1. donepezil (10mg/day) vs placebo

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Cognitive function (change from baseline at 24 weeks) ITT‐LOCF Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Subtotals only

1.1 ADAS‐Cog 13 item

1

262

Mean Difference (IV, Fixed, 95% CI)

1.90 [0.51, 3.29]

1.2 NYU Paragraph Test Delayed Recall

1

262

Mean Difference (IV, Fixed, 95% CI)

0.30 [‐0.41, 1.01]

1.3 NYU Paragraph Test Immediate Recall

1

262

Mean Difference (IV, Fixed, 95% CI)

0.60 [‐0.11, 1.31]

1.4 WMS (Wechsler) Digit Span Backwards

1

262

Mean Difference (IV, Fixed, 95% CI)

0.5 [‐0.05, 1.05]

1.5 Symbol Digit Modalities

1

262

Mean Difference (IV, Fixed, 95% CI)

1.7 [‐0.11, 3.51]

2 Total number of withdrawals at 24 weeks Show forest plot

1

270

Odds Ratio (M‐H, Fixed, 95% CI)

2.37 [1.33, 4.22]

3 Total number of withdrawals due to adverse event at 24 weeks Show forest plot

1

270

Odds Ratio (M‐H, Fixed, 95% CI)

3.54 [1.65, 7.60]

4 Total number of patients who suffered at least one adverse event by 24 weeks Show forest plot

1

270

Odds Ratio (M‐H, Fixed, 95% CI)

2.52 [1.34, 4.76]

5 Total number of patients who suffered at least one adverse event of diarrhoea by 24 weeks Show forest plot

1

270

Odds Ratio (M‐H, Fixed, 95% CI)

4.71 [2.23, 9.97]

6 Total number of patients who suffered at least one adverse event of nausea by 24 weeks Show forest plot

1

270

Odds Ratio (M‐H, Fixed, 95% CI)

2.52 [1.10, 5.75]

7 Total number of patients who suffered at least one adverse event of vomiting by 24 weeks Show forest plot

1

270

Peto Odds Ratio (Peto, Fixed, 95% CI)

8.30 [2.61, 26.37]

8 Total number of patients who suffered at least one adverse event of leg cramps by 24 weeks Show forest plot

1

270

Peto Odds Ratio (Peto, Fixed, 95% CI)

4.63 [1.58, 13.55]

9 Total number of patients who suffered at least one adverse event of abnormal dreams by 24 weeks Show forest plot

1

270

Peto Odds Ratio (Peto, Fixed, 95% CI)

5.31 [2.61, 10.79]

10 Total number of patients who suffered at least one adverse event of depression by 24 weeks Show forest plot

1

270

Odds Ratio (M‐H, Fixed, 95% CI)

6.43 [0.76, 54.11]

11 Total number of patients who suffered at least one adverse event of insomnia by 24 weeks Show forest plot

1

270

Odds Ratio (M‐H, Fixed, 95% CI)

2.18 [0.85, 5.60]

12 Number who progress to AD or another dementia after 1 year of treatment Show forest plot

1

512

Odds Ratio (M‐H, Fixed, 95% CI)

0.39 [0.21, 0.72]

13 Number who progress to AD or another dementia after 3 years of treatment Show forest plot

1

512

Odds Ratio (M‐H, Fixed, 95% CI)

0.84 [0.57, 1.25]

Figuras y tablas -
Comparison 1. donepezil (10mg/day) vs placebo